Morales; Shawn A
Patent Applications and Registrations
Patent applications and USPTO patent grants for Morales; Shawn A.The latest application filed is for "rnai agents for inhibiting expression of 17beta-hsd type 13 (hsd17b13), compositions thereof, and methods of use".
- Morales; Shawn A - San Diego CA
- Morales; Shawn A. - Pasadena CA US
| Patent | Date |
|---|---|
| RNAi Agents for Inhibiting Expression of 17beta-HSD Type 13 (HSD17B13), Compositions Thereof, and Methods of Use App 20220056454 - Li; Zhen ; et al. | 2022-02-24 |
| Epithelial membrane protein-2 (EMP2) and proliferative vitroretinopathy (PVR) Grant 9,464,135 - Gordon , et al. October 11, 2 | 2016-10-11 |
| Epithelial Membrane Protein 2 (emp2) Binding Reagents And Their Therapeutic Uses In Ocular Diseases App 20130034555 - Gordon; Lynn K. ; et al. | 2013-02-07 |
| Epithelial Membrane Protein-2 (emp2) And Proliferative Vitroretinopathy (pvr) App 20130004493 - Gordon; Lynn K. ; et al. | 2013-01-03 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 